Literature DB >> 10722487

Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.

L Poirel1, T Naas, D Nicolas, L Collet, S Bellais, J D Cavallo, P Nordmann.   

Abstract

Pseudomonas aeruginosa COL-1 was identified in a blood culture of a 39-year-old-woman treated with imipenem in Marseilles, France, in 1996. This strain was resistant to beta-lactams, including ureidopenicillins, ticarcillin-clavulanic acid, cefepime, ceftazidime, imipenem, and meropenem, but remained susceptible to the monobactam aztreonam. The carbapenem-hydrolyzing beta-lactamase gene of P. aeruginosa COL-1 was cloned, sequenced, and expressed in Escherichia coli DH10B. The deduced 266-amino-acid protein was an Ambler class B beta-lactamase, with amino acid identities of 32% with B-II from Bacillus cereus; 31% with IMP-1 from several gram-negative rods in Japan, including P. aeruginosa; 27% with CcrA from Bacteroides fragilis; 24% with BlaB from Chryseobacterium meningosepticum; 24% with IND-1 from Chryseobacterium indologenes; 21% with CphA-1 from Aeromonas hydrophila; and 11% with L-1 from Stenotrophomonas maltophilia. It was most closely related to VIM-1 beta-lactamase recently reported from Italian P. aeruginosa clinical isolates (90% amino acid identity). Purified VIM-2 beta-lactamase had a pI of 5.6, a relative molecular mass of 29.7 kDa, and a broad substrate hydrolysis range, including penicillins, cephalosporins, cephamycins, oxacephamycins, and carbapenems, but not monobactams. As a metallo-beta-lactamase, its activity was zinc dependent and inhibited by EDTA (50% inhibitory concentration, 50 microM). VIM-2 conferred a resistance pattern to beta-lactams in E. coli DH10B that paralleled its in vitro hydrolytic properties, except for susceptibility to ureidopenicillins, carbapenems, and cefepime. bla(VIM-2) was located on a ca. 45-kb plasmid that in addition conferred resistance to sulfamides and that was not self-transmissible either from P. aeruginosa to E. coli or from E. coli to E. coli. bla(VIM-2) was the only gene cassette located within the variable region of a novel class 1 integron, In56, that was weakly related to the bla(VIM-1)-containing integron. VIM-2 is the second carbapenem-hydrolyzing metalloenzyme characterized from a P. aeruginosa isolate outside Japan.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722487      PMCID: PMC89788          DOI: 10.1128/AAC.44.4.891-897.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates.

Authors:  G J Da Silva; G J Leitão; L Peixe
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate.

Authors:  L Lauretti; M L Riccio; A Mazzariol; G Cornaglia; G Amicosante; R Fontana; G M Rossolini
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

3.  Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B beta-lactamase showing a broad substrate profile.

Authors:  G M Rossolini; N Franceschini; M L Riccio; P S Mercuri; M Perilli; M Galleni; J M Frere; G Amicosante
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

4.  Structure of In31, a blaIMP-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes.

Authors:  N Laraki; M Galleni; I Thamm; M L Riccio; G Amicosante; J M Frère; G M Rossolini
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

5.  Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates.

Authors:  L Poirel; M Guibert; D Girlich; T Naas; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

6.  Molecular characterization of a carbapenem-hydrolyzing beta-lactamase from Chryseobacterium (Flavobacterium) indologenes.

Authors:  S Bellais; S Léotard; L Poirel; T Naas; P Nordmann
Journal:  FEMS Microbiol Lett       Date:  1999-02-15       Impact factor: 2.742

7.  Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene.

Authors:  L Poirel; T Naas; M Guibert; E B Chaibi; R Labia; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

8.  Structure and function of 59-base element recombination sites associated with mobile gene cassettes.

Authors:  H W Stokes; D B O'Gorman; G D Recchia; M Parsekhian; R M Hall
Journal:  Mol Microbiol       Date:  1997-11       Impact factor: 3.501

Review 9.  Metallo-beta-lactamases: a class apart.

Authors:  K Bush
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079

10.  The crystal structure of the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia at 1.7 A resolution.

Authors:  J H Ullah; T R Walsh; I A Taylor; D C Emery; C S Verma; S J Gamblin; J Spencer
Journal:  J Mol Biol       Date:  1998-11-20       Impact factor: 5.469

View more
  198 in total

1.  What's New in beta-lactamases?

Authors:  Patricia A. Bradford
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

2.  Standard numbering scheme for class B beta-lactamases.

Authors:  M Galleni; J Lamotte-Brasseur; G M Rossolini; J Spencer; O Dideberg; J M Frère
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

3.  Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-beta-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae.

Authors:  J J Yan; W C Ko; J J Wu
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

4.  First isolation of a carbapenem-hydrolyzing beta-lactamase in Pseudomonas aeruginosa in Spain.

Authors:  Guillem Prats; Elisenda Miro; Beatriz Mirelis; Laurent Poirel; Samuel Bellais; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

5.  Efficacy of beta-lactams for treating experimentally induced pneumonia due to a carbapenem-hydrolyzing metallo-beta-lactamase-producing strain of Pseudomonas aeruginosa.

Authors:  Samuel Bellais; Olivier Mimoz; Sophie Léotard; Anne Jacolot; Olivier Petitjean; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

6.  Novel 3-N-aminoglycoside acetyltransferase gene, aac(3)-Ic, from a Pseudomonas aeruginosa integron.

Authors:  Maria Letizia Riccio; Jean-Denis Docquier; Emanuela Dell'Amico; Francesco Luzzaro; Gianfranco Amicosante; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

7.  Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain.

Authors:  F Lopez-Otsoa; L Gallego; K J Towner; L Tysall; N Woodford; D M Livermore
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

8.  Clinical strain of Pseudomonas aeruginosa carrying a bla(TEM-21) gene located on a chromosomal interrupted TnA type transposon.

Authors:  Véronique Dubois; Corinne Arpin; Patrick Noury; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

9.  Novel variant (bla(VIM-4)) of the metallo-beta-lactamase gene bla(VIM-1) in a clinical strain of Pseudomonas aeruginosa.

Authors:  Spyros Pournaras; Athanassios Tsakris; Maria Maniati; Leonidas S Tzouvelekis; Antonios N Maniatis
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

10.  EBR-1, a novel Ambler subclass B1 beta-lactamase from Empedobacter brevis.

Authors:  Samuel Bellais; Delphine Girlich; Amal Karim; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.